Cargando…
Corticosteroids in COVID-19: one size does not fit all
Organising pneumonia and acute fibrinous and organising pneumonia have been reported as the predominant patterns in pathological samples from COVID-19 patients. Critically ill COVID-19 patients may benefit even more from higher corticosteroid doses. https://bit.ly/3timqPM
Autores principales: | Gogali, Athena, Kyriakopoulos, Chris, Kostikas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877324/ https://www.ncbi.nlm.nih.gov/pubmed/33574071 http://dx.doi.org/10.1183/13993003.00224-2021 |
Ejemplares similares
-
Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022) -
Identification and treatment of T2-low asthma in the era of biologics
por: Kyriakopoulos, Chris, et al.
Publicado: (2021) -
Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020) -
COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)